17-20 June, 2019
Boston, MA



We recently had the chance to sit down and speak with Mike Romanos, CEO at Microbiotica – an emerging biotech with a cutting-edge approach to microbiome-based therapeutics and diagnostics.

We spoke about what challenges lie ahead for translational microbiome research  but also why we should be excited about the future.

Click here to download


The Microbiome Movement – Drug Development Summit 2017 Post Event Report

Download to read Dana Barberio, Msc, Edge Bioscience Communications’ Microbiome Drug Development Summit 2017 Post Event Report.

Click here to download